US Stock Movement: Iovance surged on October 9 with revenue increase and Amtagvi
Bitget异动解读2026/10/09 14:30Iovance October 9th Surge Analysis
Keywords: Revenue upgrade, Amtagvi
1. On September 29, the company raised its full-year 2026 total revenue guidance from $350 million–$370 million to $410 million–$420 million. The midpoint increased by $55 million, or about 15%, and exceeds the consensus estimate of $402.8 million, driving up revenue expectations.
2. In the second quarter of 2026, the company achieved record product revenue of $99.3 million. Demand in the US market for Amtagvilifileucel and Proleukin was strong. The authorized treatment center network has expanded to about 100 centers, with plans to reach at least 110 by the end of 2026, providing visibility for third and fourth quarter revenues.
(Disclaimer: This content is generated by AI technology summarizing public information and is for reference only; it does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Stock Movement: Amazon surged on October 9 driven by AWS growth, Meta ban, and e-commerce promotions
Trump says Russia will release over 300,000 tons of diesel globally
International oil prices have dropped sharply in the short term, with both WTI and Brent crude falling more than $1 in a short period. Trump announced that Putin has agreed to supply diesel to the global market, with Russia set to provide over 300,000 tons of diesel to the US and worldwide.
Crypto prices
More
